Insider Buying: Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) CFO Buys 6,100 Shares of Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) CFO David West Griffin acquired 6,100 shares of Calumet Specialty Products Partners, L.P. stock in a transaction dated Friday, July 28th. The stock was purchased at an average cost of $5.24 per share, for a total transaction of $31,964.00. Following the completion of the purchase, the chief financial officer now directly owns 43,152 shares in the company, valued at $226,116.48. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

David West Griffin also recently made the following trade(s):

  • On Friday, August 4th, David West Griffin acquired 553 shares of Calumet Specialty Products Partners, L.P. stock. The stock was purchased at an average cost of $5.31 per share, for a total transaction of $2,936.43.
  • On Tuesday, August 1st, David West Griffin acquired 2,100 shares of Calumet Specialty Products Partners, L.P. stock. The stock was purchased at an average cost of $5.20 per share, for a total transaction of $10,920.00.
  • On Monday, July 31st, David West Griffin acquired 3,000 shares of Calumet Specialty Products Partners, L.P. stock. The stock was purchased at an average cost of $5.21 per share, for a total transaction of $15,630.00.
  • On Wednesday, August 2nd, David West Griffin purchased 8,100 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $5.19 per share, for a total transaction of $42,039.00.
  • On Thursday, July 27th, David West Griffin purchased 3,000 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $5.14 per share, for a total transaction of $15,420.00.
  • On Wednesday, July 26th, David West Griffin purchased 3,000 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $5.34 per share, for a total transaction of $16,020.00.
  • On Tuesday, July 25th, David West Griffin purchased 3,783 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $5.02 per share, for a total transaction of $18,990.66.
  • On Thursday, July 20th, David West Griffin purchased 800 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $4.49 per share, for a total transaction of $3,592.00.
  • On Monday, July 17th, David West Griffin purchased 6,369 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $4.14 per share, for a total transaction of $26,367.66.
  • On Wednesday, July 12th, David West Griffin purchased 3,000 shares of Calumet Specialty Products Partners, L.P. stock. The shares were bought at an average cost of $4.19 per share, for a total transaction of $12,570.00.

Shares of Calumet Specialty Products Partners, L.P. (NASDAQ CLMT) traded up 5.71% during trading on Tuesday, hitting $5.55. The company’s stock had a trading volume of 925,662 shares. The company’s market capitalization is $425.64 million. The firm’s 50 day moving average is $4.55 and its 200-day moving average is $4.09. Calumet Specialty Products Partners, L.P. has a 1-year low of $2.79 and a 1-year high of $6.42.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) last released its earnings results on Friday, August 4th. The oil and gas company reported $0.12 earnings per share for the quarter, topping the consensus estimate of ($0.46) by $0.58. Calumet Specialty Products Partners, L.P. had a negative return on equity of 47.22% and a negative net margin of 2.81%. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $841 million. Analysts forecast that Calumet Specialty Products Partners, L.P. will post ($1.17) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by BBNS and is the sole property of of BBNS. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://baseballnewssource.com/markets/insider-buying-calumet-specialty-products-partners-l-p-nasdaqclmt-cfo-acquires-6100-shares-of-stock-updated/1305008.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC boosted its position in shares of Calumet Specialty Products Partners, L.P. by 239.7% in the fourth quarter. Renaissance Technologies LLC now owns 534,700 shares of the oil and gas company’s stock worth $2,139,000 after buying an additional 377,300 shares during the last quarter. Adams Asset Advisors LLC boosted its position in shares of Calumet Specialty Products Partners, L.P. by 54.0% in the first quarter. Adams Asset Advisors LLC now owns 630,600 shares of the oil and gas company’s stock worth $2,396,000 after buying an additional 221,100 shares during the last quarter. Linscomb & Williams Inc. boosted its position in shares of Calumet Specialty Products Partners, L.P. by 0.6% in the first quarter. Linscomb & Williams Inc. now owns 98,163 shares of the oil and gas company’s stock worth $373,000 after buying an additional 600 shares during the last quarter. Wells Fargo & Company MN boosted its position in shares of Calumet Specialty Products Partners, L.P. by 2.5% in the first quarter. Wells Fargo & Company MN now owns 461,750 shares of the oil and gas company’s stock worth $1,754,000 after buying an additional 11,265 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in shares of Calumet Specialty Products Partners, L.P. by 5.0% in the first quarter. Fifth Third Bancorp now owns 31,800 shares of the oil and gas company’s stock worth $121,000 after buying an additional 1,500 shares during the last quarter. Institutional investors own 11.29% of the company’s stock.

Several equities analysts recently commented on the company. BidaskClub raised Calumet Specialty Products Partners, L.P. from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Zacks Investment Research lowered Calumet Specialty Products Partners, L.P. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 20th. Cowen and Company reaffirmed a “hold” rating and issued a $5.00 target price on shares of Calumet Specialty Products Partners, L.P. in a research report on Friday, July 14th. Finally, Wells Fargo & Company raised Calumet Specialty Products Partners, L.P. from a “market perform” rating to an “outperform” rating and set a $6.00 target price on the stock in a research report on Wednesday, May 10th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $4.46.

About Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products in North America. The Company operates through three segments: specialty products, fuel products and oilfield services. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Insider Buying and Selling by Quarter for Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

Receive News & Ratings for Calumet Specialty Products Partners L.P. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P. and related companies with our FREE daily email newsletter.

 


Latest News

Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury
Chicago Cubs Must Survive Without Willson Contreras
Chicago Cubs Must Survive Without Willson Contreras
Cleveland Indians Acquire Jay Bruce From New York Mets
Cleveland Indians Acquire Jay Bruce From New York Mets
Injury to CC Sabathia Adds to Yankees’ Concerns
Injury to CC Sabathia Adds to Yankees’ Concerns
Darren Daulton Former Catcher with Phillies Dies
Darren Daulton Former Catcher with Phillies Dies


Leave a Reply

 
© 2006-2017 BBNS.